Literature DB >> 29878197

Impaired Prefrontal Cortical Dopamine Release in Schizophrenia During a Cognitive Task: A [11C]FLB 457 Positron Emission Tomography Study.

Naren Rao1,2, Georg Northoff3, Abanti Tagore1, Pablo Rusjan1, Miran Kenk1, Alan Wilson1, Sylvain Houle1, Antonio Strafella1, Gary Remington1, Romina Mizrahi1.   

Abstract

Evidence from several lines of research suggests decreased dopamine release in the prefrontal cortex as the neurochemical correlates of cognitive deficits in schizophrenia (SCZ). However, in vivo examination of cortical hypodopaminergia using positron emission tomography (PET) during cognitive task performance in SCZ remains to be investigated. We examined dopamine release in anterior cingulate cortex (ACC) and dorsolateral prefrontal cortex (DLPFC), using PET while participants were performing a cognitive task. Thirteen drug-free patients with SCZ and 13 healthy volunteers (HV) matched for age and sex participated in the study. Data were acquired between 2011 and 2015. Two PET scans with [11C]FLB 457 were acquired while the participants were performing the Wisconsin Card Sorting Test (WCST) and a sensorimotor control task (SMCT). A magnetic resonance image was acquired for anatomical delineation. Differences in cortical dopamine release between SCZ and HV, indexed as percentage change in binding potential between WCST and SMCT (ΔBPND), were calculated in ACC and DLPFC. We observed significant differences in the ΔBPND in ACC (HV = 4.40 ± 6.00; SCZ = -11.48 ± 15.08; t = 3.52; P = .003) and a trend-level difference in ΔBPND in DLPFC (HV = -0.58 ± 8.45; SCZ = -7.79 ± 11.28; t = 1.84; P = .079), suggesting dopamine depletion in cortical brain regions in patients with SCZ while performing a cognitive task. These results provide the first in vivo evidence for reduced dopamine release or even dopamine depletion while performing cognitive task in ACC and DLPFC in patients with SCZ. The present results provide support for the frontal hypodopaminergia hypothesis of cognitive symptoms in SCZ.
© The Author(s) 2018. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  PET; cognition; hypodopaminergia; psychosis

Mesh:

Substances:

Year:  2019        PMID: 29878197      PMCID: PMC6483585          DOI: 10.1093/schbul/sby076

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  67 in total

1.  Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain.

Authors:  H Olsson; C Halldin; C G Swahn; L Farde
Journal:  J Cereb Blood Flow Metab       Date:  1999-10       Impact factor: 6.200

Review 2.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

3.  Reliability and validity of a depression rating scale for schizophrenics.

Authors:  D Addington; J Addington; E Maticka-Tyndale; J Joyce
Journal:  Schizophr Res       Date:  1992-03       Impact factor: 4.939

Review 4.  Neurocognition: clinical and functional outcomes in schizophrenia.

Authors:  Martin Lepage; Michael Bodnar; Christopher R Bowie
Journal:  Can J Psychiatry       Date:  2014-01       Impact factor: 4.356

5.  Striatal dopamine release during performance of executive functions: A [(11)C] raclopride PET study.

Authors:  Oury Monchi; Ji Hyun Ko; Antonio P Strafella
Journal:  Neuroimage       Date:  2006-09-18       Impact factor: 6.556

Review 6.  Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review.

Authors:  M Laruelle
Journal:  J Cereb Blood Flow Metab       Date:  2000-03       Impact factor: 6.200

Review 7.  Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

Authors:  M F Green; R S Kern; D L Braff; J Mintz
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

8.  Rostral anterior cingulate cortex dysfunction during error processing in schizophrenia.

Authors:  Kristin R Laurens; Elton T C Ngan; Alan T Bates; Kent A Kiehl; Peter F Liddle
Journal:  Brain       Date:  2003-03       Impact factor: 13.501

9.  High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.

Authors:  Nicholas T Vandehey; Jeffrey M Moirano; Alexander K Converse; James E Holden; Jogesh Mukherjee; Dhanabalan Murali; R Jerry Nickles; Richard J Davidson; Mary L Schneider; Bradley T Christian
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-30       Impact factor: 6.200

10.  Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys.

Authors:  A F Arnsten; J X Cai; B L Murphy; P S Goldman-Rakic
Journal:  Psychopharmacology (Berl)       Date:  1994-10       Impact factor: 4.530

View more
  7 in total

1.  Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia.

Authors:  Daniel R Garton; Ana R Montaño-Rodríguez; Soophie Olfat; Kärt Mätlik; Feride Eren; Laoise Casserly; Anastasios Damdimopoulos; Anne Panhelainen; L Lauriina Porokuokka; Jaakko J Kopra; Giorgio Turconi; Nadine Schweizer; Erika Bereczki; Fredrik Piehl; Göran Engberg; Simon Cervenka; T Petteri Piepponen; Fu-Ping Zhang; Petra Sipilä; Johan Jakobsson; Carl M Sellgren; Sophie Erhardt; Jaan-Olle Andressoo
Journal:  Mol Psychiatry       Date:  2022-05-26       Impact factor: 15.992

Review 2.  Psychosis spectrum illnesses as disorders of prefrontal critical period plasticity.

Authors:  Sophia Vinogradov; Matthew V Chafee; Erik Lee; Hirofumi Morishita
Journal:  Neuropsychopharmacology       Date:  2022-09-30       Impact factor: 8.294

3.  Dopamine and glutamate in schizophrenia: biology, symptoms and treatment.

Authors:  Robert A McCutcheon; John H Krystal; Oliver D Howes
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

4.  D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients.

Authors:  Per Stenkrona; Granville J Matheson; Christer Halldin; Simon Cervenka; Lars Farde
Journal:  Int J Neuropsychopharmacol       Date:  2019-07-01       Impact factor: 5.176

Review 5.  Linking mPFC circuit maturation to the developmental regulation of emotional memory and cognitive flexibility.

Authors:  Cassandra B Klune; Benita Jin; Laura A DeNardo
Journal:  Elife       Date:  2021-05-05       Impact factor: 8.713

6.  Resting-state dopaminergic cell firing in the ventral tegmental area negatively regulates affiliative social interactions in a developmental animal model of schizophrenia.

Authors:  Hidekazu Sotoyama; Hisaaki Namba; Yutaro Kobayashi; Taku Hasegawa; Dai Watanabe; Ena Nakatsukasa; Kenji Sakimura; Tomoyuki Furuyashiki; Hiroyuki Nawa
Journal:  Transl Psychiatry       Date:  2021-04-22       Impact factor: 6.222

Review 7.  Strategies to solve the reverse inference fallacy in future MRI studies of schizophrenia: a review.

Authors:  Chuanjun Zhuo; Gongying Li; Xiaodong Lin; Deguo Jiang; Yong Xu; Hongjun Tian; Wenqiang Wang; Xueqin Song
Journal:  Brain Imaging Behav       Date:  2021-04       Impact factor: 3.224

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.